
|Articles|March 1, 2007
ED after prostate cancer treatment may be underreported
Las Vegas-Researchers don't agree on how to measure erectile function and dysfunction, making it difficult to determine the effects of prostate cancer treatment on patients' sex lives, said Johns Hopkins researchers who presented a review of 592 articles at the Sexual Medicine Society of North America fall meeting here.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Kristen Scarpato, MD, on combination strategies in BCG-naïve NMIBC
2
Veda Giri, MD, on patient-reported outcomes with prostate cancer genetic testing
3
Trial to compare 225Ac-PSMA-617 vs 177Lu-PSMA-617 for oligorecurrent prostate cancer
4
Amanda North, MD, recaps SWIU 2026 session on imposter syndrome
5






